Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies

Bryan J. Schneider*, Gregory P. Kalemkerian, Deborah Bradley, David C. Smith, Merrill J. Egorin, Stephanie Daignault, Rodney Dunn, Maha Hussain

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint Dive into the research topics of 'Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences